SQSTM1 and Paget’s Disease of Bone

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Calcified Tissue International

• Publication date

  2004-09-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00223-004-0041-0PMID 15365659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel UBA Domain Mutations of SQSTM1 in Paget's Disease of Bone: Genotype Phenotype Correlation, Functional Analysis, and Structural Consequences

  2004influential reference
• The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis.

  2004influential reference
• Two Novel Mutations at Exon 8 of the Sequestosome 1 (SQSTM1) Gene in an Italian Series of Patients Affected by Paget's Disease of Bone (PDB)

  2004cited by this paper
• Two novel mutations at exon 8 of Sequestosome 1 gene (SQSTM 1)in an Italian series of patient affected by Paget’s disease of bone (PDB)

  2004cited by this paper
• CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members

  2003cited by this paper
• Molecular Recognition in Dimerization between PB1 Domains*

  2003cited by this paper
• Structure of the Ubiquitin-associated Domain of p62 (SQSTM1) and Implications for Mutations That Cause Paget's Disease of Bone*

  2003cited by this paper
• Interaction Codes within the Family of Mammalian Phox and Bem1p Domain-containing Proteins*

  2003cited by this paper
• Three Novel Mutations in SQSTM1 Identified in Familial Paget's Disease of Bone

  2003cited by this paper
• The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

  2003cited by this paper
• Mechanism of ubiquitin recognition by the CUE domain of Vps9p.

  2003cited by this paper
• Faculty Opinions recommendation of CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

  2003cited by this paper
• The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome.

  2003cited by this paper
• PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62.

  2003cited by this paper
• Transferring substrates to the 26S proteasome.

  2003cited by this paper
• Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates

  2003cited by this paper
• Genetic regulation of osteoclast development and function

  2003cited by this paper
• Phenotypic Characterization of Early Onset Paget's Disease of Bone Caused by a 27‐bp Duplication in the TNFRSF11A Gene

  2003cited by this paper
• Ubiquitin binding proteins protect ubiquitin conjugates from disassembly

  2003cited by this paper
• Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts.

  2003cited by this paper
• Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders.

  2003cited by this paper
• Rad23 Ubiquitin-associated Domains (UBA) Inhibit 26 S Proteasome-catalyzed Proteolysis by Sequestering Lysine 48-linked Polyubiquitin Chains*

  2003cited by this paper
• Incidence and Natural History of Paget's Disease of Bone in England and Wales

  2002cited by this paper
• Rad23 Promotes the Targeting of Proteolytic Substrates to the Proteasome

  2002cited by this paper
• Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.

  2002cited by this paper
• Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome

  2002cited by this paper
• Expansile Skeletal Hyperphosphatasia Is Caused by a 15‐Base Pair Tandem Duplication in TNFRSF11A Encoding RANK and Is Allelic to Familial Expansile Osteolysis

  2002cited by this paper
• A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.

  2002cited by this paper
• Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation

  2002cited by this paper
• Osteoprotegerin deficiency and juvenile Paget's disease.

  2002cited by this paper
• Structure and functional properties of the ubiquitin binding protein p62

  2002cited by this paper
• Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.

  2002cited by this paper
• Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.

  2002cited by this paper
• Osteoprotegerin deficiency and juvenile Paget's disease.

  2002cited by this paper
• Mallory body—A disease‐associated type of sequestosome

  2002cited by this paper
• Linkage of Paget disease of bone to a novel region on human chromosome 18q23.

  2002cited by this paper
• p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.

  2002cited by this paper
• Paget's Disease in an Archeological Population

  2002cited by this paper
• Evaluation of the role of RANK and OPG genes in Paget's disease of bone.

  2001cited by this paper
• Mutation Screening of the TNFRSF11A Gene Encoding Receptor Activator of NFkB (RANK) in Familial and Sporadic Paget's Disease of Bone and Osteosarcoma

  2001cited by this paper
• Proteins containing the UBA domain are able to bind to multi-ubiquitin chains

  2001cited by this paper
• TAK1 is a ubiquitin-dependent kinase of MKK and IKK

  2001cited by this paper
• Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35.

  2001cited by this paper
• GABAA receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1

  2001cited by this paper
• Ubiquitin‐associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi‐ubiquitin chain assembly

  2001cited by this paper
• UBA domains mediate protein-protein interactions between two DNA damage-inducible proteins.

  2001cited by this paper
• Paget disease of bone: mapping of two loci at 5q35-qter and 5q31.

  2001cited by this paper
• Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I

  2001cited by this paper
• Mouse models of abnormal skeletal development and homeostasis.

  2001cited by this paper
• Familial Paget's Disease of Bone: Nonlinkage to the PDB1 and PDB2 Loci on Chromosomes 6p and 18q in a Large Pedigree

  2001cited by this paper
• UBA domains of DNA damage-inducible proteins interact with ubiquitin

  2001cited by this paper
• The selective vulnerability of nerve cells in Huntington's disease

  2001cited by this paper
• The Atypical Protein Kinase C-interacting Protein p62 Is a Scaffold for NF-κB Activation by Nerve Growth Factor*

  2001cited by this paper
• The ubiquitin protein catabolic disorders

  2001cited by this paper
• The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway

  2000cited by this paper
• Recognition of the polyubiquitin proteolytic signal

  2000cited by this paper
• Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation

  2000cited by this paper
• T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

  2000cited by this paper
• Long-term trends in the incidence of Paget's disease of bone.

  2000cited by this paper
• Heterogeneity in Paget disease of the bone.

  2000cited by this paper
• Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

  2000influential reference
• Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.

  2000cited by this paper
• A Negative Search for a Paramyxoviral Etiology of Paget's Disease of Bone: Molecular, Immunological, and Ultrastructural Studies in U.K. Patients

  2000cited by this paper
• 3-Methyladenine-DNA Glycosylase (MPG Protein) Interacts with Human RAD23 Proteins*

  2000cited by this paper
• TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.

  2000cited by this paper
• Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q.

  2000cited by this paper
• TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.

  1999cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice

  1999cited by this paper
• The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation

  1999cited by this paper
• Activation of IkappaB kinase beta by protein kinase C isoforms.

  1999influential reference
• Activation of IκB Kinase β by Protein Kinase C Isoforms

  1999cited by this paper
• Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.

  1999cited by this paper
• P62 and the sequestosome, a novel mechanism for protein metabolism

  1998influential reference
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Paget's Disease of Bone: Evidence for a Susceptibility Locus on Chromosome 18q and for Genetic Heterogeneity

  1998influential reference
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998cited by this paper
• SMART, a simple modular architecture research tool: identification of signaling domains.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Ubiquitin Lys63 is involved in ubiquitination of a yeast plasma membrane protein

  1997cited by this paper
• Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male rats.

  1997cited by this paper
• Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein.

  1997cited by this paper
• Genetic linkage of Paget disease of the bone to chromosome 18q.

  1997influential reference
• Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair

  1997cited by this paper
• ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins.

  1996cited by this paper
• p62, a Phosphotyrosine-independent Ligand of the SH2 Domain of p56lck, Belongs to a New Class of Ubiquitin-binding Proteins*

  1996cited by this paper
• The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway.

  1996cited by this paper
• PEST sequences and regulation by proteolysis.

  1996cited by this paper
• Seeking the elusive etiology of paget disease: A progress report

  1996cited by this paper
• Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain.

  1996cited by this paper
• Frequency and characteristics of familial aggregation of paget's disease of bone

  1995cited by this paper
• A ubiquitin mutant with specific defects in DNA repair and multiubiquitination

  1995cited by this paper
• A Proteolytic Pathway That Recognizes Ubiquitin as a Degradation Signal (*)

  1995cited by this paper
• Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions.

  1994cited by this paper
• Genetic linkage of familial expansile osteolysis to chromosome 18q.

  1994cited by this paper
• Pathophysiology and Treatment of Paget's Disease of Bone

  1991cited by this paper
• A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.

  1989cited by this paper
• Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years

  1986cited by this paper
• A family study of Paget's disease of bone.

  1983cited by this paper
• Ultrastructural features of the osteoclasts from Paget's disease of bone in relation to a viral aetiology.

  1982cited by this paper

• A 5-year Chinese longitudinal case report on the malignant transformation of spinal Paget disease

  2026influential citation
• Translational insights into Duchenne muscular dystrophy: network biomarker identification and drug repositioning through multi-omics approaches

  2025cites this paper
• Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget’s Disease of Bone

  2023cites this paper
• Slingshot homolog-1 amplifies mitochondrial abnormalities by distinctly impairing health and clearance of mitochondria.

  2023cites this paper
• The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

  2022cites this paper
• Updates on Paget’s Disease of Bone

  2022cites this paper
• Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis

  2021cites this paper
• The high stability of the three-helix bundle UBA domain of p62 protein as revealed by molecular dynamics simulations

  2021cites this paper
• Genetic Determinants of Paget’s Disease of Bone

  2021cites this paper
• CUL5–ASB6 Complex Promotes p62/SQSTM1 Ubiquitination and Degradation to Regulate Cell Proliferation and Autophagy

  2021cites this paper
• Spastic Paraplegia with Paget's Disease of Bone due to a VCP Gene Mutation

  2020cites this paper
• Enfermedad de Paget de hueso esporádica. Serie de casos y revisión de la literatura

  2020cites this paper
• Sporadic Paget's disease of the bone. Case series and literature review

  2020cites this paper
• Pattern of SQSTM1 Gene Variants in a Hungarian Cohort of Paget’s Disease of Bone

  2020cites this paper
• [Paget's disease of bone: Diagnostic and therapeutic updates].

  2018cites this paper
• Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy

  2018cites this paper
• Modélisation et analyses physiopathologiques de la Sclérose Latérale Amyotrophique liée à l'ubiquiline 2 à l'aide de vecteurs AAV10

  2017cites this paper
• Novel TRAF6-Protein Interactions and the Molecular Mechanisms by Which They Regulate TRAF6 Dependent Signaling

  2016cites this paper
• Enfermedad ósea de Paget

  2016cites this paper
• Genetics of Paget's disease of bone.

  2015cites this paper
• Preoperative Management of Paget’s Disease

  2015cites this paper
• Selective autophagic receptor p62 regulates the abundance of transcriptional coregulator ARIP4 during nutrient starvation

  2015cites this paper
• Maladie osseuse de Paget

  2015cites this paper
• Genetics of Paget’s Disease of Bone

  2014cites this paper
• Secular changes in Paget’s disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain

  2013cites this paper
• Chapter 19 – Genetics of Paget’s Disease of Bone

  2013cites this paper
• New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.

  2013cites this paper
• Expression, localisation and functional analysis of cytoskeletal motor proteins in bone resorbing osteoclasts

  2013cites this paper
• Interaction Domains of p62: A Bridge Between p62 and Selective Autophagy

  2013cites this paper
• IDENTIFICATION OF SUMOYLATED PROTEINS AND INVESTIGATION OF PROTEIN UBIQUITINATION IN THE NF-κB PATHWAY

  2012cites this paper
• Paget's disease of bone: evidence for complex pathogenetic interactions.

  2012cites this paper
• Pharmacotherapy of Paget's disease of bone

  2012cites this paper
• Sequestosome 1/p62: a multi-domain protein with multi-faceted functions

  2012cites this paper
• UNIVERSITY OF SIENA Department of Biotechnologies Doctorate in Genetics, Oncology and Clinical Medicine Ph. D in Genetics and Physiopathology of Skeletal Disorders GENETICS AND PHARMACOGENETICS OF PAGET’S DISEASE OF BONE

  2012cites this paper
• Pathogenesis of Paget Disease of Bone

  2012cites this paper
• Genetic determinants of Paget's disease of bone

  2011cites this paper
• Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms.

  2011cites this paper
• [Paget's disease: clinical update].

  2011cites this paper
• Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition.

  2011cites this paper
• CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes

  2010cites this paper
• The majority of the genetic risk for Paget’s disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes

  2010cites this paper
• SQSTM1 mutations and Paget's disease of bone

  2010cites this paper
• Involvement of the osteoblast in Paget's disease of bone.

  2009cites this paper
• Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover

  2009cites this paper
• Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.

  2009cites this paper
• Absence of somatic SQSTM1 mutations in Paget's disease of bone.

  2009cites this paper
• Regulation of the p62 promoter by oxidative damage in neurodegenerative disease and aging

  2009cites this paper
• Paget’s disease of bone

  2009cites this paper
• Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia

  2008cites this paper
• Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.

  2008cites this paper
• Use of p62/SQSTM1 antibodies for neuropathological diagnosis

  2008cites this paper
• Pathogenesis and management of Paget's disease of bone.

  2008cites this paper
• Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

  2008cites this paper
• Diagnosis and treatment of Paget's disease of bone.

  2007cites this paper
• Ubiquitin-mediated signalling and Paget's disease of bone

  2007influential citation
• Identification of a Major Locus for Paget's Disease on Chromosome 10p13 in Families of British Descent

  2007cites this paper
• Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.

  2007cites this paper
• Enfermedad de Paget ósea

  2007cites this paper
• Maladie osseuse de Paget

  2007cites this paper
• Delayed Development of Paget's Disease in Offspring Inheriting SQSTM1 Mutations

  2007cites this paper
• Pathophysiology and genetics of metabolic bone disorders characterized by increased bone turnover.

  2007cites this paper
• Identification of Sex‐Specific Associations Between Polymorphisms of the Osteoprotegerin Gene, TNFRSF11B, and Paget's Disease of Bone

  2007cites this paper
• Giriş: Kemiğin Paget hastaliği (PH) ilk defa 1876 yilinda Sir James Paget tarafindan kemiğin kronik bir inflamasyonu olarak tanimlanmiş ve osteitis deformans olarak isimlendirmiştir

  2007cites this paper
• The molecular pathogenesis of Paget disease of bone

  2007cites this paper
• The pathogenesis of osteoclast diseases: Some knowns, but still many unknowns

  2007cites this paper
• Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.

  2007cites this paper
• A Novel Mutation (K378X) in the Sequestosome 1 Gene Associated With Increased NF‐κB Signaling and Paget's Disease of Bone With a Severe Phenotype

  2006cites this paper
• Meeting Report from the 2nd Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society: June 25-29, 2005 in Geneva, Switzerland

  2006cites this paper
• Meeting report from skeletal complications of malignancy IV

  2006cites this paper
• Differential Gene Expression in Cultured Osteoblasts and Bone Marrow Stromal Cells From Patients With Paget's Disease of Bone

  2006cites this paper
• STUDY OF THE ACTIN-RELATED PROTEIN 2/3 COMPLEX AND OSTEOCLAST BONE RESORPTION

  2006cites this paper
• Paget's Disease of Bone in Italy

  2006cites this paper
• Guidelines for diagnosis and management of Paget's disease of bone in Japan

  2006cites this paper
• Loss of Ubiquitin Binding Is a Unifying Mechanism by Which Mutations of SQSTM1 Cause Paget’s Disease of Bone

  2006cites this paper
• MEETING REPORTS Meeting Report from the 2nd Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society

  2006cites this paper
• Mechanisms of Disease: genetics of Paget's disease of bone and related disorders

  2006cites this paper
• p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

  2006cites this paper
• TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src

  2006cites this paper
• p62 mutations, ubiquitin recognition and Paget's disease of bone.

  2006cites this paper
• Identification and Molecular Characterization of a Novel Splice-Site Mutation (G1205C) in the SQSTM1 Gene Causing Paget’s Disease of Bone in an Extended American Family

  2006cites this paper
• Effects of nutrition on bone density Related review : Osteoporosis nutrition beyond calcium : update 2005

  2005cites this paper
• Ubiquitin-binding proteins: similar, but different.

  2005cites this paper
• Loss of Ubiquitin‐Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations

  2004cites this paper
• Pathogenesis of Paget's disease of bone

  2002cites this paper
• Genetics of Paget's disease of bone.

  1998cites this paper